Aparna Parikh, MD, MS, Discusses Balancing Physical Fitness, Family Life, and Her Work in the GI Space

Video

Aparna Parikh, MD, MS, discusses how her early experiences with physical fitness shaped her current relationship with exercise.

Aparna Parikh's passion for fitness started early on with a love for competitive tennis in high school and college. Throughout her time in premed, Parikh continued to stay active, but it was a move to the San Francisco Bay area during her fellowship that gave her an appreciation of the great outdoors. She began biking to work and even swimming in the San Francisco Bay, leading into her first triathlon, which she completed while pregnant with her first child. In addition to discussing her passion for being physically active, she describes how she balances remaining active with saving lives at the Mass General Cancer Center in Boston, Massachusetts, and spending time with her family.

Recent Videos
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Computational models help researchers anticipate how ADCs may behave in later lines of development, while they are still in the early stages.
ADC payloads with high levels of potency can sometimes lead to higher levels of toxicity, which can eliminate the therapeutic window for patients with cancer.
According to Greg Thurber, PhD, target-mediated uptake is the biggest driver of efficacy for antibody-drug conjugates as a cancer treatment.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to expect at the 43rd Annual Chemotherapy Foundation Symposium, such as new chemotherapeutics and targeted therapies.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Related Content